PlexPress Closes $2.75M Seed Funding Round, Plans to Launch TRAC Platform in Fall | GenomeWeb

PlexPress, a spinout of Finland's VTT Technical Research Center that specializes in multiplex gene-expression analysis, announced this week that it has secured $2.75 million in an initial venture capital seed funding round to help it launch its technology platform by the third quarter.

PlexPress' core technology, transcription analysis with affinity capture, or TRAC, was developed by researchers at VTT to provide high-content gene-expression analysis of between two and 150 genes in up to several thousand samples.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.